0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Data Visualization Market by Technology, Data Type, Platform Type, Device Type, Deployment Mode, Application, End-User - Global Forecast to 2030- Product Image
Biological Data Visualization Market by Technology, Data Type, Platform Type, Device Type, Deployment Mode, Application, End-User - Global Forecast to 2030- Product Image
Sale

Biological Data Visualization Market by Technology, Data Type, Platform Type, Device Type, Deployment Mode, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011392
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Data Visualization Market grew from USD 706.75 million in 2024 to USD 772.62 million in 2025. It is expected to continue growing at a CAGR of 9.77%, reaching USD 1.23 billion by 2030.

Setting the Stage for Next-Generation Biological Data Visualization

Biological data visualization has emerged as a critical enabler in decoding complex life science information and driving breakthroughs across research, diagnostics, and therapeutic development. As high-throughput instruments and multi-omics approaches generate unprecedented volumes of data, researchers and decision-makers face mounting challenges in converting raw outputs into actionable insights. This introduction outlines the evolution of visualization tools from static charts to dynamic, interactive platforms that facilitate real-time exploration of genomic sequences, proteomic networks, and cellular interactions.

Over the past decade, advances in microscopy, mass spectrometry, sequencing technologies, and artificial intelligence have converged to create immersive visualization experiences. Interactive dashboards now allow users to navigate intricate biological pathways, pinpoint potential biomarkers, and simulate molecular interactions with unparalleled precision. As a result, project timelines have contracted and collaborative research across institutions has accelerated, fueling innovation in precision medicine, environmental monitoring, and agricultural biotechnology. This section sets the context for understanding how emerging tools are transforming data interpretation, stakeholder collaboration, and the strategic deployment of life science investments.

Unveiling Disruptive Trends Reshaping Visualization Strategies

The biological data visualization landscape is undergoing transformative shifts driven by technological convergence and evolving user demands. Machine learning algorithms are increasingly embedded within visualization platforms, enabling pattern recognition in genomic variants and proteomic profiles that would elude manual analysis. Single-cell sequencing visualization has matured from rudimentary cluster plots to multidimensional representations that highlight cellular heterogeneity in disease tissues and developmental processes.

Simultaneously, cloud computing and edge analytics are reshaping data access and collaboration. Research teams spread across continents can now explore interactive visualizations of high-volume datasets in real time, without local infrastructure constraints. Hybrid architectures blend on-premise security with cloud scalability, granting organizations the flexibility to comply with data privacy regulations while leveraging global computational resources. Furthermore, the integration of virtual and augmented reality is opening new frontiers for immersive exploration of three-dimensional biological structures, enhancing training programs and accelerating hypothesis generation. These converging trends are redefining expectations for speed, scalability, and depth of insight in biological data visualization.

Assessing the Impact of New US Tariffs on Visualization Ecosystems

The United States’ tariff adjustments effective in 2025 are poised to exert substantial influence on the biological data visualization market. Increased duties on imported imaging systems, reagents, and specialized microfluidic devices will inflate acquisition costs for end-users, prompting many organizations to reassess procurement strategies. Domestic manufacturers may capitalize on this shift by expanding production capacities and forging strategic alliances to mitigate supply chain vulnerabilities and maintain price stability.

In response to higher input costs, global vendors are exploring alternative sourcing models, including nearshoring components and negotiating multi-year supply agreements to preserve margins. Research institutes and pharmaceutical companies may delay upgrades to high-end sequencing platforms or opt for refurbished systems, potentially altering the adoption curve of cutting-edge visualization technologies. Nonetheless, tariff-driven cost pressures also incentivize innovation in software-based solutions that reduce reliance on hardware-intensive processes. As stakeholders navigate this altered economic landscape, adaptability and strategic procurement planning will become paramount to sustaining research productivity and competitive positioning.

Decoding Market Segments to Uncover Growth and Innovation

A nuanced understanding of market segmentation reveals where growth and innovation intersect within biological data visualization. On the technology front, flow cytometry-based visualization and microscopy-driven imaging continue to dominate, yet mass spectrometry and sequencing-based visualization platforms are rapidly gaining traction, spurred by demands for high-resolution molecular profiles. Magnetic resonance-based techniques remain indispensable for in vivo studies, while X-ray crystallography visualization underpins structural biology breakthroughs.

Data type segmentation highlights the ascendancy of genomic visualization as researchers delve into whole-genome and targeted sequencing projects, though proteomic and metabolomic visualizations are essential for comprehensive biomarker discovery. Transcriptomic visualization has emerged as a vital bridge, contextualizing gene expression dynamics within broader molecular networks. The distinction between integrated bioinformatics suites and standalone visualization tools underscores the market’s preference for holistic platforms that streamline workflow management, yet specialized tools retain relevance for niche applications.

Application segmentation illuminates the critical role of clinical and medical research in driving demand, while agriculture and horticulture science leverage visualization for crop improvement and pathogen detection. Marine biology and environmental science are unlocking insights through environmental DNA data visualization and marine microbiome mapping, expanding the utility of visualization platforms beyond traditional laboratory settings. Finally, end-user dynamics reveal that pharmaceutical and biotechnology firms lead adoption, but research institutes-both academic laboratories and government research centers-play a pivotal role in pioneering novel visualization methodologies and validating emerging technologies.

Navigating Regional Dynamics Shaping Global Adoption

Regional dynamics exert a profound influence on market trajectories as stakeholders navigate regulatory frameworks, infrastructure maturity, and funding landscapes. The Americas maintain a leading position, driven by robust investment in precision medicine initiatives, expansive research funding, and a concentration of key instrument manufacturers. Europe, the Middle East & Africa benefit from collaborative networks among academic consortia and national health agencies, fostering standardized protocols and cross-border research programs. In contrast, the Middle East is cultivating niche centers of excellence in genomics and environmental monitoring, leveraging public-private partnerships to accelerate adoption.

Asia-Pacific stands out for its rapid uptake of mobile and cloud-based visualization tools, propelled by government-led digital health initiatives and significant investment in biotech hubs. Regional players are investing in local manufacturing capabilities to mitigate import costs and comply with evolving trade policies. Together, these regional insights underscore the importance of tailoring go-to-market strategies to address varied regulatory climates, infrastructure readiness, and funding mechanisms, ensuring that visualization solutions meet the unique needs of each geography.

Profiling Pioneers Driving Technological Leadership

Leading corporations are shaping the competitive landscape through strategic collaborations, targeted investments, and product portfolio expansions. One global life sciences supplier has fortified its software suite with machine learning capabilities, enabling seamless integration with its existing instrument base. Another pioneering firm has established partnerships with cloud service providers to offer scalable, compliant visualization solutions that address data sovereignty concerns.

Innovative startups are also carving niches by focusing on user-friendly, mobile-first applications that democratize access to complex datasets. Established providers are responding by acquiring these agile competitors to bolster their analytics capabilities and accelerate time to market. Meanwhile, traditional instrument manufacturers are enhancing interoperability between their hardware platforms and third-party software, recognizing that open ecosystems foster broader adoption and customer loyalty. These strategic maneuvers highlight a competitive ecosystem where collaboration and agility are critical to maintaining leadership positions.

Strategic Imperatives to Secure Competitive Advantage

Industry leaders must embrace a multipronged approach to stay ahead in the evolving visualization market. Investing in unified platforms that integrate multi-omics data will enable organizations to deliver holistic insights while reducing platform fragmentation. Forming strategic alliances with cloud and edge computing providers can optimize performance and security, ensuring compliance with data governance requirements across jurisdictions. To offset tariff pressures, supply chain diversification and long-term procurement contracts are essential to stabilize costs and maintain access to critical components.

Tailoring visualization offerings for emerging applications in environmental monitoring and agricultural genomics will unlock new revenue streams and demonstrate value beyond traditional biomedical research. Strengthening partnerships with academic and government research centers fosters early-stage validation of novel visualization methodologies and accelerates technology transfer. Finally, enhancing user experience through intuitive interfaces and mobile compatibility will drive adoption among wider research communities, from bench scientists to data analysts. By implementing these strategies, market participants can navigate economic headwinds, capitalize on growth opportunities, and reinforce competitive differentiation.

Rigorous Methodology Underpinning Our Market Insights

Our research methodology combines rigorous data triangulation with qualitative insights from industry stakeholders. We conducted comprehensive secondary research by reviewing peer-reviewed journals, company filings, regulatory disclosures, and technology white papers. To validate findings, we engaged in structured interviews with subject matter experts across instrument manufacturers, software developers, end-users, and policy advisors. This primary research was complemented by quantitative analyses of patent filings, funding trends, and academic publications to identify emerging technologies and market validation patterns.

We applied a multi-dimensional analytical framework that incorporates technology readiness assessments, value chain mapping, and regulatory impact analysis. Geographic and segmentation overlays were used to ensure that insights reflect regional nuances and end-user requirements. Throughout the process, we adhered to stringent quality control protocols, including peer reviews and consistency checks, to guarantee the reliability and validity of our conclusions.

Converging Insights and Strategic Takeaways

In synthesizing these insights, it becomes clear that the biological data visualization market is entering a phase of intelligent innovation and strategic realignment. Technological synergies between AI, cloud computing, and high-throughput instruments are elevating visualization from static representations to dynamic, predictive analytics platforms. At the same time, economic factors-such as the revised US tariff structure-are reshaping procurement strategies and accelerating the shift toward software-driven solutions.

Segment-level analysis highlights areas of rapid expansion, notably sequencing-based and mass spectrometry visualizations, while regional assessments underscore the need for tailored approaches in the Americas, EMEA, and Asia-Pacific. Competitive activity demonstrates that partnerships, acquisitions, and open ecosystem strategies are paramount to sustaining market leadership. Ultimately, organizations that align their innovation roadmaps with these industrial, economic, and regulatory forces will be best positioned to capitalize on the transformative potential of biological data visualization.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Flow Cytometry-Based Visualization
    • Magnetic Resonance Imaging (MRI) Visualization
    • Mass Spectrometry-Based Visualization
    • Microscopy-Based Visualization
    • Sequencing-Based Visualization
    • X-ray Crystallography Visualization
  • Data Type
    • Genomic Data
    • Metabolomic Data
    • Proteomic Data
    • Transcriptomic Data
  • Platform Type
    • Integrated Bioinformatics Suites
    • Standalone Visualization Tools
  • Device Type
    • Desktop & Laptop Applications
    • Mobile & Tablet Applications
  • Deployment Mode
    • Cloud-based
    • Hybrid
    • On-premise
  • Application
    • Agriculture & Horticulture Science
    • Clinical & Medical Research
    • Marine Biology & Environmental Science
      • Environmental DNA (eDNA) Data Visualization
      • Marine Microbiome Visualization
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research Institutes
      • Academic Laboratories
      • Government Research Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Agilent Technologies, Inc.
  • AnalyzeDirect
  • Candelis Corporation
  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • Clarivate
  • Danaher Corporation
  • Dotmatics
  • Esaote S.p.A
  • GE HealthCare Technologies Inc.
  • Golden Helix
  • Media Cybernetics, Inc. by Roper Industries, Inc
  • MetaCell LLC, LTD.
  • MR Solutions Ltd.
  • Oxford Instruments PLC
  • Pluto Bioinformatics
  • QIAGEN GmbH
  • Revvity, Inc.
  • Salesforce, Inc.
  • Scientific Volume Imaging B.V.
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • ZONTAL INC.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Current Market Position, Its Significance, and Historical Evolution Driving Market Expansion and Challenges
3.2. Consumer Preferences Trends, Product Standardization Impact, Competitive Dynamics, and Regional Regulatory Responses
3.3. Market Maturation Stage Intellectual Property Landscape Analysis and Strategic Commercialization Approaches
3.4. Future Market Outlook, Growth Opportunities, Emerging Technologies, and New Application Areas
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Data Visualization Market, by Technique
8.1. Introduction
8.2. Genomics Visualization
8.2.1. DNA Sequencing Visualization
8.2.2. Epigenomics Visualization
8.2.3. RNA Sequencing Visualization
8.3. Metabolomics Visualization
8.3.1. Metabolic Pathway Visualization
8.3.2. Metabolite Profiling Visualization
8.4. Proteomics Visualization
8.4.1. Mass Spectrometry Visualization
8.4.2. Protein-Protein Interaction Visualization
9. Biological Data Visualization Market, by Application
9.1. Introduction
9.2. Agriculture & Livestock
9.2.1. Animal Breeding
9.2.2. Crop Improvement
9.2.3. Pathogen Resistance
9.3. Clinical Diagnostics
9.3.1. Cancer Genomics
9.3.2. Pathogen Diagnostics
9.3.3. Prenatal Screening
9.4. Drug Discovery
9.4.1. Biomarker Discovery
9.4.2. Lead Optimization
9.4.3. Target Identification
10. Biological Data Visualization Market, by Data Type
10.1. Introduction
10.2. Genomic Data
10.2.1. Copy Number Variants
10.2.2. Single Nucleotide Polymorphisms
10.2.3. Transcription Factor Binding Sites
10.3. Metabolomic Data
10.3.1. Enzyme Activities
10.3.2. Metabolite Concentrations
10.4. Proteomic Data
10.4.1. Amino Acid Sequences
10.4.2. Post-Translational Modifications
10.4.3. Protein Structures
11. Biological Data Visualization Market, by End-User
11.1. Introduction
11.2. Healthcare Providers
11.2.1. Clinics
11.2.2. Diagnostic Laboratories
11.2.3. Hospitals
11.3. Pharmaceutical & Biotechnology Companies
11.3.1. Manufacturing Units
11.3.2. Research and Development Departments
11.4. Research Institutes
11.4.1. Academic Laboratories
11.4.2. Government Research Centers
12. Biological Data Visualization Market, by Software Type
12.1. Introduction
12.2. Commercial Software
12.2.1. GeneSpring
12.2.2. Partek
12.2.3. Qlucore
12.3. Open Source Software
12.3.1. Bioconductor
12.3.2. Galaxy
12.3.3. R Programming Packages
13. Biological Data Visualization Market, by Device Type
13.1. Introduction
13.2. Desktop & Laptop Applications
13.2.1. Linux-Based Software
13.2.2. Mac-Based Software
13.2.3. Windows-Based Software
13.3. Mobile & Tablet Applications
13.3.1. Android Apps
13.3.2. iOS Apps
14. Americas Biological Data Visualization Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Biological Data Visualization Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Biological Data Visualization Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. 3mensio Medical Imaging B.V. by Esaote group
17.3.2. Agilent Technologies, Inc.
17.3.3. Canon Medical Systems Corporation
17.3.4. Carestream Health, Inc.
17.3.5. Carl Zeiss AG
17.3.6. Clarivate
17.3.7. Danaher Corporation
17.3.8. GE HealthCare Technologies Inc.
17.3.9. Genedata AG
17.3.10. IMSTAR SAS
17.3.11. Media Cybernetics, Inc.
17.3.12. MR Solutions Ltd.
17.3.13. Olympus Corporation
17.3.14. Oxford Instruments PLC
17.3.15. QIAGEN GmbH
17.3.16. Scientific Volume Imaging B.V.
17.3.17. Siemens Healthineers AG
17.3.18. Tempus Labs, Inc.
17.3.19. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICAL DATA VISUALIZATION MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICAL DATA VISUALIZATION MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICAL DATA VISUALIZATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOLOGICAL DATA VISUALIZATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOLOGICAL DATA VISUALIZATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICAL DATA VISUALIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DNA SEQUENCING VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY EPIGENOMICS VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RNA SEQUENCING VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLIC PATHWAY VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLITE PROFILING VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MASS SPECTROMETRY VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PATHOGEN RESISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PATHOGEN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COPY NUMBER VARIANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TRANSCRIPTION FACTOR BINDING SITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY ENZYME ACTIVITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLITE CONCENTRATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AMINO ACID SEQUENCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY POST-TRANSLATIONAL MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEIN STRUCTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MANUFACTURING UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH AND DEVELOPMENT DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENESPRING, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PARTEK, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY QLUCORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY BIOCONDUCTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GALAXY, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY R PROGRAMMING PACKAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY LINUX-BASED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MAC-BASED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY WINDOWS-BASED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY ANDROID APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY IOS APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 153. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 154. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 155. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 156. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 157. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 159. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 161. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 162. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 163. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 164. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 165. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 167. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 170. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 171. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 172. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 174. CANADA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 176. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 177. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 178. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 179. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 181. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 183. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 184. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 185. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 186. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 187. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 189. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 190. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 193. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 194. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 195. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 265. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 266. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 267. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 268. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 269. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 271. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 272. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 273. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DATA TYPE, 2018-2030 (USD MILLION)
TABLE 274. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMIC DATA, 2018-2030 (USD MILLION)
TABLE 275. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMIC DATA, 2018-2030 (USD MILLION)
TABLE 276. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMIC DATA, 2018-2030 (USD MILLION)
TABLE 277. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 279. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 280. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 282. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY COMMERCIAL SOFTWARE, 2018-2030 (USD MILLION)
TABLE 283. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY OPEN SOURCE SOFTWARE, 2018-2030 (USD MILLION)
TABLE 284. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 285. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY DESKTOP & LAPTOP APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 286. CHINA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY MOBILE & TABLET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 287. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 288. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY GENOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 289. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY METABOLOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 290. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY PROTEOMICS VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 291. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY AGRICULTURE & LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 293. INDIA BIOLOGICAL DATA VISUALIZATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. INDIA BIOLOGICAL DA

Companies Mentioned

The companies profiled in this Biological Data Visualization market report include:
  • Agilent Technologies, Inc.
  • AnalyzeDirect
  • Candelis Corporation
  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • Clarivate
  • Danaher Corporation
  • Dotmatics
  • Esaote S.p.A
  • GE HealthCare Technologies Inc.
  • Golden Helix
  • Media Cybernetics, Inc. by Roper Industries, Inc
  • MetaCell LLC, LTD.
  • MR Solutions Ltd.
  • Oxford Instruments PLC
  • Pluto Bioinformatics
  • QIAGEN GmbH
  • Revvity, Inc.
  • Salesforce, Inc.
  • Scientific Volume Imaging B.V.
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • ZONTAL INC.

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 772.62 Million
Forecasted Market Value ( USD ) by 2030 $ 1230 Million
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Sequencing, MRI), Application, Platform (Windows, Mac OS), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Sequencing, MRI), Application, Platform (Windows, Mac OS), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
EUR$5,950USDGBP
Biological Data Visualization - Global Strategic Business Report - Product Image

Biological Data Visualization - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
EUR$5,850USDGBP
Biological Data Visualization Market Report 2025 - Product Image

Biological Data Visualization Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Biological Data Visualization Market Size, Share & Trends Analysis Report By Technique, By Platform, By Application, By End Use, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Biological Data Visualization Market Size, Share & Trends Analysis Report By Technique, By Platform, By Application, By End Use, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 332 Pages
  • Global
From
EUR$3,600USDGBP
Data Visualization Tools Market by Deployment Model, Component, Tool Type, Industry Vertical, Organization Size, Data Type - Global Forecast to 2030 - Product Image

Data Visualization Tools Market by Deployment Model, Component, Tool Type, Industry Vertical, Organization Size, Data Type - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP

About the Biological Data Visualization Market

The Biological Data Visualization market is a subset of the larger Data Analytics market. It focuses on the visualization of biological data, such as gene expression, protein-protein interactions, and metabolic pathways. This data is used to gain insights into the biological processes of living organisms, such as disease progression and drug efficacy. Biological Data Visualization tools allow researchers to quickly and easily explore and analyze large datasets, identify patterns, and draw conclusions. Companies in the Biological Data Visualization market include Cytoscape, Genome Compiler, GenomeVx, GenoViz, and VisANT. These companies provide software solutions for visualizing and analyzing biological data, as well as services such as data integration, data mining, and data analysis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.